Baxter International Inc (BAX) - Financial and Strategic SWOT Analysis Review

Date: May 8, 2018
Pages: 68
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B71F3E46D61EN
Leaflet:

Download PDF Leaflet

Baxter International Inc (BAX) - Financial and Strategic SWOT Analysis Review
Baxter International Inc (BAX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Baxter International Inc (Baxter) is a provider of healthcare products, including dialysis in acute and chronic conditions, sterile intravenous solutions, parenteral nutrition therapies, generic injectable pharmaceuticals, infusion systems and devices, inhaled anesthetics, and surgical hemostat and sealant products. The company’s products find application in hospitals, kidney dialysis centers, rehabilitation centers, nursing homes and clinics, besides patients at home under physician supervision. Baxter distributes its products through direct sales force and also through a network of independent distributors, drug wholesalers, specialty pharmacies and other alternative site providers. The company has operations in the Americas, the Middle East, Africa, Europe and Asia-Pacific. Baxter is headquartered in Deerfield, Illinois, the US.

Baxter International Inc Key Recent Developments

May 02,2018: Baxter and the International Society of Nephrology Announce a Collaboration to Address Growing Prevalence of Kidney Disease
Apr 26,2018: Baxter Reports First-Quarter 2018 Results And Increases Financial Outlook For Full-Year 2018
Feb 13,2018: Baxter to Present at the Barclays Global Healthcare Conference
Feb 01,2018: Baxter Reports 2017 Fourth-Quarter and Full-Year Results
Nov 17,2017: Statement by FDA Commissioner Scott Gottlieb, M.D., on efforts to address impact of IV fluid shortages following hurricane destruction and resolve manufacturing shortfalls

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

NOTE: Out of security concerns GlobalData requires using corporate email address.
SECTION 1 - ABOUT THE COMPANY

Baxter International Inc - Key Facts
Baxter International Inc - Key Employees
Baxter International Inc - Key Employee Biographies
Baxter International Inc - Major Products and Services
Baxter International Inc - History
Baxter International Inc - Company Statement
Baxter International Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Company Overview
Baxter International Inc - Business Description
Product Category: Acute Therapies
Overview
Performance
Product Category: Advanced Surgery
Overview
Performance
Product Category: APAC (Asia-Pacific)
Performance
Target Markets
Product Category: Medication Delivery
Overview
Performance
Product Category: Nutrition
Overview
Performance
Product Category: Other
Overview
Performance
Product Category: Pharmaceuticals
Overview
Performance
Product Category: Renal Care
Overview
Performance
Geographical Segment: Americas
Target Markets
Performance
Geographical Segment: EMEA (Europe, Middle East and Africa)
Performance
R&D Overview
Baxter International Inc - Corporate Strategy
Baxter International Inc - SWOT Analysis
SWOT Analysis - Overview
Baxter International Inc - Strengths
Baxter International Inc - Weaknesses
Baxter International Inc - Opportunities
Baxter International Inc - Threats
Baxter International Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Baxter International Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Baxter International Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018
Baxter International Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 02, 2018: Baxter and the International Society of Nephrology Announce a Collaboration to Address Growing Prevalence of Kidney Disease
Apr 26, 2018: Baxter Reports First-Quarter 2018 Results And Increases Financial Outlook For Full-Year 2018
Feb 01, 2018: Baxter Reports 2017 Fourth-Quarter and Full-Year Results
Nov 02, 2017: Baxter Supports 27 Abstract Presentations at ASN Kidney Week to Advance Scientific Exchange Focused on New Standards of Renal Care
Oct 25, 2017: Baxter Reports Third-Quarter 2017 Results and Updates Financial Outlook For Full-Year 2017
Oct 12, 2017: Baxter Provides Update on Puerto Rico Recovery Status Post Hurricane Maria
Sep 07, 2017: Baxter Recognized as Responsible and Sustainable Business for 18th Consecutive Year by Dow Jones Sustainability Index
Aug 31, 2017: Baxter and MATTER Healthcare Incubator Partner on Patient-Driven Innovation
Jul 26, 2017: Baxter Reports Second-Quarter 2017 Results and Provides Updated Financial Outlook for 2017 and 2020
Jul 17, 2017: Baxter Appoints Cathy R. Smith to its Board

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Baxter International Inc, Key Facts
Baxter International Inc, Key Employees
Baxter International Inc, Key Employee Biographies
Baxter International Inc, Major Products and Services
Baxter International Inc, History
Baxter International Inc, Subsidiaries
Baxter International Inc, Joint Venture
Baxter International Inc, Key Competitors
Baxter International Inc, Ratios based on current share price
Baxter International Inc, Annual Ratios
Baxter International Inc, Annual Ratios (Cont.1)
Baxter International Inc, Annual Ratios (Cont.2)
Baxter International Inc, Interim Ratios
Baxter International Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Baxter International Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018
Baxter International Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Baxter International Inc, Performance Chart (2013 - 2017)
Baxter International Inc, Ratio Charts
Baxter International Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Baxter International Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018

COMPANIES MENTIONED

NxStage Medical Inc
Medtronic Plc
Johnson & Johnson
Hospira Inc
Fresenius Medical Care AG & Co KGaA
Boston Scientific Corp
Becton Dickinson and Co
Skip to top


Ask Your Question

Baxter International Inc (BAX) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: